Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bisphosphonates and bone metastases.

Literature DB >> 3064797

Bisphosphonates and bone metastases.

A R Morton¹, A Howell.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Diphosphonates

Year: 1988 PMID： 3064797 PMCID： PMC2246834 DOI： 10.1038/bjc.1988.257

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

× No keyword cloud information.

10 in total

1. Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP.

Authors: D Thiébaud; P Jaeger; A F Jacquet; P Burckhardt
Journal: J Clin Oncol Date: 1988-05 Impact factor: 44.544

2. Absorption of oral diphosphonate in normal subjects.

Authors: I Fogelman; L Smith; R Mazess; M A Wilson; J A Bevan
Journal: Clin Endocrinol (Oxf) Date: 1986-01 Impact factor: 3.478

3. The effects of diphosphonates on the exchangeable and non-exchangeable calcium and phosphate of hydroxyapatite.

Authors: W G Robertson; D B Morgan; H Fleisch; M D Francis
Journal: Biochim Biophys Acta Date: 1971-02-28

4. Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.

Authors: A R Morton; J A Cantrill; G V Pillai; A McMahon; D C Anderson; A Howell
Journal: BMJ Date: 1988-09-24

5. Influence of a diphosphonate on the cellular aspect of young bone tissue.

Authors: C M Plasmans; P H Jap; W Kuijpers; T J Slooff
Journal: Calcif Tissue Int Date: 1980 Impact factor: 4.333

6. Effect of single high dose infusions of aminohydroxypropylidene diphosphonate on hypercalcaemia caused by cancer.

Authors: B M Cantwell; A L Harris
Journal: Br Med J (Clin Res Ed) Date: 1987-02-21

7. Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy.

Authors: A R Morton; J A Cantrill; A E Craig; A Howell; M Davies; D C Anderson
Journal: Br Med J (Clin Res Ed) Date: 1988-03-19

8. Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment.

Authors: A T van Holten-Verzantvoort; O L Bijvoet; F J Cleton; J Hermans; H M Kroon; H I Harinck; P Vermey; J W Elte; J P Neijt; L V Beex
Journal: Lancet Date: 1987-10-31 Impact factor: 79.321

9. Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

Authors: I Elomaa; C Blomqvist; P Gröhn; L Porkka; A L Kairento; K Selander; C Lamberg-Allardt; T Holmström
Journal: Lancet Date: 1983-01-22 Impact factor: 79.321

10. Structure-activity relationships of various bisphosphonates.

Authors: H Shinoda; G Adamek; R Felix; H Fleisch; R Schenk; P Hagan
Journal: Calcif Tissue Int Date: 1983 Impact factor: 4.333